Survivin mediates the anti-apoptotic effect of δ-opioid receptor stimulation in cardiomyocytes

Journal of Cell Science

Volumn 120, Issue 5, 2007, Pages 895-907

  Yao, Ling Ling ^a   Wang, Yong Gang ^b   Cai, Wen Jie ^a   Yao, Tai ^a   Zhu, Yi Chun ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

opioid receptor; Apoptosis; Cardiomyocyte; DADLE; Survivin

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; LEUCINE ENKEPHALIN; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NALOXONE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SURVIVIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIVISION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE TARGETING; HEART INFARCTION SIZE; HEART MUSCLE CELL; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOSOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GLUCOSE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID, DELTA; RNA INTERFERENCE; TIME FACTORS;

EID: 34047163503     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03393     Document Type: Article

References (28)

1. Abbate, A., Scarpa, S., Santini, D., Palleiro, J., Vasaturo, F., Miller, J., Morales, C., Vetrovec, G. W. and Baldi, A. (2005). Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int. J. Cardiol. 111, 371-376.
2. Altieri, D. C. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22, 8581-8589.
3. Ambrosini, G., Adida, C. and Altieri, D. C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
4. Asanuma, H., Torigoe, T., Kamiguchi, K., Hirohashi, Y., Ohmura, T., Hirata, K., Sato, M. and Sato, N. (2005). Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/ AKT signaling pathway in breast cancer cells. Cancer Res. 65, 11018-11025.
5. Berra, E., Milanini J., Richard, D. E., Le Gall, M., Vinals, F., Gothie, E., Roux, D., Pages, G. and Pouyssegur, J. (2000). Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem. Pharmacol. 60, 1171-1178.
6. Bishopric, N. H., Andreka, P., Slepak, T. and Webster, K. A. (2001). Molecular mechanisms of apoptosis in the cardiac myocyte. Curr. Opin. Pharmacol. 1, 141-150.
7. Bueno, O. E and Molkentin, J. D. (2002). Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91, 776-781.
8. Fryer, R. M., Hsu, A. K. and Gross, G. J. (2001a). ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res. Cardiol. 96, 136-142.
9. Fryer, R. M., Pratt, P. F., Hsu, A. K. and Gross, G. J. (2001b). Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J. Pharmacol. Exp. Ther. 296, 642-649.
10. Fukuda, S, Kaga, S., Sasaki, H., Zhan, L., Zhu, L., Otani, H., Kalfin, R., Das, D. K. and Maulik, N. (2004). Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J. Mol. Cell. Cardiol. 36, 547-559.
11. Haunstetter, A. and Izumo, S. (1998). Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82, 1111-1129.
12. Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D. and Reed, J. C. (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997-5002.
13. Kumar, D., Lou, H. and Singal, P. K. (2002). Oxidative stress and apoptosis in heart dysfunction. Herz 27, 662-668.
14. Liang, B. T. and Gross, G. J. (1999). Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ. Res. 84, 1396-1400.
15. Miki, T., Cohen, M. V. and Downey, J. M. (1998). Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol. Cell. Biochem. 186, 3-12.
16. Okubo, S., Tanabe, Y., Takeda, K., Kitayama, M., Kanemitsu, S., Kukreja, R. C. and Takekoshi, N. (2004). Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am. J. Physiol. Heart Circ. Physiol. 287, H1786-H1791.
17. Patel, H. H.,Hsu, A. K., Peart J.N. and Gross, G.J. (2002). Sarcolemmal K(ATP) channel triggers opioid-induced delayed cardioprotection in the rat. Circ. Res. 91, 186-188.
18. Santini, D., Abbate, A., Scarpa, S., Vasaturo, F., Biondi-Zoccai, G. G., Bussani, R., De Giorgio, R, Bassan, F., Camilot, D., Di Marino, M. P. et al. (2004). Survivin acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. J. Clin. Pathol. 57, 1321-1324.
19. Schultz, J. E., Hsu, A. K. and Gross, G. J. (1998). Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 97, 1282-1289.
20. Takemura, G., Kato, S., Aoyama, T., Hayakawa, Y., Kanoh, M., Maruyama, R., Arai, M., Nishigaki, K., Minatoguchi, S., Fukuda, K. et al. (2001). Characterization of ultrastructure and its relation with DNA fragmentation in Fas-induced apoptosis of cultured cardiac myocytes. J. Pathol. 193, 546-556.
21. Tatsumi, T., Shiraishi, J., Keira, N., Akashi, K., Mano, A., Yamanaka, S., Matoba, S., Fushiki, S., Fliss, H. and Nakagawa, M. (2003). Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59, 428-440.
22. Valks, D. M., Kemp, T. J. and Clerk, A. (2003). Regulation of Bcl-xL expression by H202 in cardiac myocytes. J. Biol. Chem. 278, 25542-25547.
23. Vaitchanova-Matchouganska, A. and Ojewole, J. A. (2003). Mechanisms of opioid delta (delta) and kappa (kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction. Cardiovasc. J. S. Afr. 14, 73-80.
24. Wang, H. J., Zhu, Y. C. and Yao, T. (2002). Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy. J. Appl. Physiol. 92, 2162-2168.
25. Wang, Y., Suominen, J. S., Hakovirta, H., Parvinen, M., Martinand-Mari, C., Toppari, J. and Robbins, I. (2004). Survivin expression in rat testis is upregulated by stem-cell factor. Mol. Cell. Endocrinol. 218, 165-174.
26. Wu, S., Li, H. Y. and Wong, T. M. (1999). Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ. Res. 84, 1388-1395.
27. Xia, W., Bisi, J., Strum, J, Liu, L., Carrick, K., Graham, K. M., Treece, A. L., Hardwicke, M. A., Dush, M., Liao, Q. et al. (2006). Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers. Cancer Res. 66, 1640-1647.
28. Zimlichman, R., Gefel, D., Eliahou, H., Matas, Z., Rosen, B., Gass, S., Ela, C., Eilam, Y., Vogel, Z. and Barg, J. (1996). Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93, 1020-1025.